Inovio Pharmaceuticals
INO
#9503
Rank
HK$1.03 B
Marketcap
HK$9.99
Share price
1.19%
Change (1 day)
-47.87%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): -HK$17.72

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$17.79. In 2025 the company made an earnings per share (EPS) of -HK$14.19 an increase over its 2024 EPS that were of -HK$30.96.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$17.7224.89%
2025-HK$14.19-54.18%
2024-HK$30.96-35.14%
2023-HK$47.74-56.62%
2022-HK$110.06-19.54%
2021-HK$136.7935.9%
2020-HK$100.66-11.57%
2019-HK$113.8315.24%
2018-HK$98.77-2.78%
2017-HK$101.606.93%
2016-HK$95.01134.88%
2015-HK$40.45-29.51%
2014-HK$57.38-57.34%
2013-HK$134.52146.55%
2012-HK$54.5620.83%
2011-HK$45.15-29.41%
2010-HK$63.97-48.48%
2009-HK$124.1710%
2008-HK$112.8811.11%
2007-HK$101.60-41.3%
2006-HK$173.09-66.91%
2005-HK$523.03110.61%
2004-HK$248.35-61.63%
2003-HK$647.20186.67%
2002-HK$225.77
2001N/A-100%
2000-HK$180.62-63.64%
1999-HK$496.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.47-484.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.03-409.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.27-157.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$58.17-426.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$28.02-257.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.47-271.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
HK$6.35-135.68%๐Ÿ‡บ๐Ÿ‡ธ USA